Research Analysts Offer Predictions for DOC FY2026 Earnings

Healthpeak Properties, Inc. (NYSE:DOC - Free Report) - Equities research analysts at Wedbush dropped their FY2026 earnings per share (EPS) estimates for shares of Healthpeak Properties in a research note issued on Monday, April 28th. Wedbush analyst R. Anderson now expects that the real estate investment trust will post earnings of $1.95 per share for the year, down from their prior estimate of $1.96. Wedbush currently has a "Outperform" rating and a $22.00 price target on the stock. The consensus estimate for Healthpeak Properties' current full-year earnings is $1.86 per share.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.46. The firm had revenue of $702.89 million for the quarter, compared to the consensus estimate of $690.76 million. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The company's revenue for the quarter was up 15.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.45 earnings per share.

A number of other brokerages also recently issued reports on DOC. Evercore ISI lowered their price objective on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Robert W. Baird dropped their price target on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Morgan Stanley upgraded shares of Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price objective on the stock in a research report on Wednesday, January 15th. StockNews.com lowered shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Thursday. Finally, Scotiabank cut their price target on shares of Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating for the company in a research note on Friday, February 28th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and nine have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $23.42.

Healthpeak Properties Price Performance

NYSE DOC traded up $0.01 on Tuesday, hitting $17.79. The stock had a trading volume of 5,480,379 shares, compared to its average volume of 4,913,319. The firm has a 50-day moving average of $19.37 and a 200-day moving average of $20.42. The company has a market capitalization of $12.36 billion, a price-to-earnings ratio of 50.83, a price-to-earnings-growth ratio of 2.17 and a beta of 1.02. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. Healthpeak Properties has a 52-week low of $17.33 and a 52-week high of $23.26.

Hedge Funds Weigh In On Healthpeak Properties

Several hedge funds and other institutional investors have recently modified their holdings of DOC. Principal Financial Group Inc. lifted its holdings in Healthpeak Properties by 2,113.5% in the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock worth $367,575,000 after buying an additional 17,314,572 shares during the period. Norges Bank bought a new stake in Healthpeak Properties in the fourth quarter valued at $166,804,000. Resolution Capital Ltd purchased a new position in Healthpeak Properties during the 4th quarter valued at $122,795,000. Long Pond Capital LP bought a new position in Healthpeak Properties in the 4th quarter worth $86,885,000. Finally, JPMorgan Chase & Co. boosted its stake in shares of Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock valued at $493,115,000 after purchasing an additional 4,056,931 shares in the last quarter. 93.57% of the stock is owned by institutional investors.

Insider Transactions at Healthpeak Properties

In other news, CEO Scott M. Brinker bought 11,337 shares of the firm's stock in a transaction that occurred on Monday, April 28th. The shares were bought at an average cost of $17.68 per share, with a total value of $200,438.16. Following the completion of the purchase, the chief executive officer now directly owns 201,863 shares in the company, valued at $3,568,937.84. This represents a 5.95 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Also, Director John T. Thomas purchased 4,200 shares of the stock in a transaction that occurred on Monday, April 28th. The shares were purchased at an average price of $17.84 per share, with a total value of $74,928.00. Following the completion of the acquisition, the director now directly owns 813,566 shares in the company, valued at $14,514,017.44. The trade was a 0.52 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 0.23% of the company's stock.

Healthpeak Properties Announces Dividend

The business also recently disclosed a dividend, which was paid on Wednesday, April 30th. Stockholders of record on Friday, April 18th were paid a dividend of $0.1017 per share. The ex-dividend date of this dividend was Thursday, April 17th. This represents a dividend yield of 6.5%. Healthpeak Properties's dividend payout ratio (DPR) is currently 305.00%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.